Atlas Trials

A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma

Clinical trial NCT07053332 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07053332
Sponsor
Jiangsu Cancer Institute & Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophagogastric Junction/Gastric Adenocarcinoma
Start date
2025-07-01
Primary completion
2027-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.